PriceTargets.com logo

NASDAQ:EVER - EverQuote Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $57.43
  • Forecasted Upside: 40.96 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$40.74 As of 03/4/2021 11:21 AM ET
▼ -3.35 (-7.60%)
1 month | 3 months | 12 months
Get New EverQuote Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVER and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVER

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$57.43
▲ +40.96% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for EverQuote in the last 3 months. The average price target is $57.43, with a high forecast of $70.00 and a low forecast of $48.00. The average price target represents a 40.96% upside from the last price of $40.74.
Buy
The current consensus among 8 contributing investment analysts is to buy stock in EverQuote. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
9/11/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/10/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
6/7/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/2/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/1/2021Raymond JamesBoost Price TargetOutperform$51.00 ➝ $58.00Low
i
2/23/2021Needham & Company LLCReiterated RatingBuy$65.00High
i
2/23/2021Raymond JamesBoost Price TargetOutperform$51.00 ➝ $58.00High
i
2/23/2021OppenheimerReiterated RatingBuy$55.00 ➝ $70.00High
i
12/16/2020JPMorgan Chase & Co.Lower Price TargetOverweight$54.00 ➝ $48.00N/A
i
11/3/2020JPMorgan Chase & Co.Lower Price TargetOverweight$60.00 ➝ $54.00N/A
i
11/3/2020OppenheimerLower Price TargetOutperform$65.00 ➝ $55.00High
i
11/3/2020Raymond JamesLower Price TargetOutperform$63.00 ➝ $51.00High
i
11/3/2020OppenheimerInitiated CoverageBuy$65.00 ➝ $55.00N/A
i
Rating by Jed Kelly at Oppenheimer Holdings Inc.
8/12/2020OppenheimerReiterated RatingBuy$65.00N/A
i
8/5/2020Needham & Company LLCBoost Price TargetBuy$55.00 ➝ $65.00N/A
i
8/5/2020Raymond JamesBoost Price TargetOutperform$49.00 ➝ $63.00N/A
i
8/5/2020Canaccord GenuityReiterated RatingBuyN/A
i
7/14/2020Bank of AmericaDowngradeNeutral ➝ Underperform$48.00N/A
i
6/2/2020OppenheimerBoost Price TargetOutperform$50.00 ➝ $65.00N/A
i
5/27/2020Canaccord GenuityBoost Price TargetBuy$50.00 ➝ $60.00N/A
i
5/5/2020JMP SecuritiesBoost Price TargetMarket Outperform$50.00 ➝ $53.00N/A
i
5/5/2020Canaccord GenuityBoost Price TargetBuy$48.00 ➝ $50.00N/A
i
5/5/2020Needham & Company LLCBoost Price TargetPositive ➝ Buy$45.00 ➝ $55.00N/A
i
5/5/2020OppenheimerReiterated RatingBuy$50.00N/A
i
Rating by Jed Kelly at Oppenheimer Holdings Inc.
3/27/2020StephensReiterated RatingBuyN/A
i
3/26/2020Needham & Company LLCLower Price TargetBuy$50.00 ➝ $45.00N/A
i
3/18/2020JPMorgan Chase & Co.Lower Price TargetOverweight$51.00 ➝ $39.00N/A
i
2/27/2020JMP SecuritiesBoost Price TargetOutperform$35.00 ➝ $50.00N/A
i
2/26/2020Bank of AmericaDowngradeBuy ➝ Neutral$45.00N/A
i
2/25/2020OppenheimerBoost Price Target$41.00 ➝ $50.00N/A
i
Rating by Jed Kelly at Oppenheimer Holdings Inc.
2/25/2020JPMorgan Chase & Co.Boost Price TargetPositive ➝ Overweight$35.00 ➝ $51.00N/A
i
2/25/2020Needham & Company LLCBoost Price TargetBuy$35.00 ➝ $50.00N/A
i
2/25/2020Raymond JamesReiterated RatingOutperform$30.00 ➝ $49.00N/A
i
2/25/2020Canaccord GenuityReiterated RatingBuy$38.00 ➝ $48.00N/A
i
Rating by Michael Graham at Canaccord Genuity
12/2/2019OppenheimerReiterated RatingBuy$33.00 ➝ $41.00N/A
i
Rating by Jed Kelly at Oppenheimer Holdings Inc.
11/5/2019OppenheimerBoost Price Target$19.00 ➝ $33.00N/A
i
11/5/2019Canaccord GenuityReiterated RatingBuy$25.00 ➝ $34.00N/A
i
Rating by Michael Graham at Canaccord Genuity
11/5/2019Raymond JamesBoost Price TargetUnderperform ➝ Buy$20.00 ➝ $30.00N/A
i
11/5/2019Needham & Company LLCBoost Price TargetBuy$27.00 ➝ $35.00N/A
i
11/5/2019JMP SecuritiesBoost Price TargetOutperform ➝ Positive$35.00N/A
i
11/5/2019Bank of AmericaUpgradeUnderperform ➝ BuyN/A
i
9/17/2019Bank of AmericaDowngradeBuy ➝ UnderperformN/A
i
8/30/2019Canaccord GenuitySet Price TargetBuy$25.00N/A
i
Rating by Michael Graham at Canaccord Genuity
8/20/2019Needham & Company LLCBoost Price TargetBuy$20.00 ➝ $27.00N/A
i
8/6/2019Needham & Company LLCBoost Price TargetBuy$20.00N/A
i
8/6/2019OppenheimerBoost Price TargetOutperform$13.00 ➝ $19.00N/A
i
8/6/2019Canaccord GenuityReiterated RatingBuy$13.00 ➝ $20.00N/A
i
8/6/2019JPMorgan Chase & Co.Boost Price TargetOverweight$14.00 ➝ $20.00N/A
i
8/6/2019JMP SecuritiesBoost Price TargetOutperform ➝ Positive$13.00 ➝ $20.00N/A
i
8/6/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$20.00N/A
i
5/7/2019JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Positive$12.00 ➝ $14.00N/A
i
5/7/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$10.00 ➝ $13.00N/A
i
4/4/2019JMP SecuritiesLower Price TargetOutperform$18.00 ➝ $12.00N/A
i
2/26/2019OppenheimerLower Price TargetOutperform$16.00 ➝ $11.00N/A
i
2/26/2019Canaccord GenuityLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00N/A
i
2/26/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$10.00N/A
i
2/26/2019Bank of AmericaUpgradeNeutral ➝ Buy$10.50N/A
i
11/13/2018Needham & Company LLCLower Price TargetBuy$15.00N/A
i
11/13/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$23.00 ➝ $18.00N/A
i
11/13/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $18.00N/A
i
11/13/2018Bank of AmericaDowngradeBuy ➝ Neutral$21.00 ➝ $15.00N/A
i
8/10/2018Needham & Company LLCInitiated CoverageBuyN/A
i
7/23/2018OppenheimerInitiated CoverageOutperform$23.00N/A
i
7/23/2018Bank of AmericaInitiated CoverageBuyN/A
i
7/23/2018William BlairReiterated RatingOutperformN/A
i
Rating by R. Schackart at William Blair
7/23/2018Canaccord GenuityInitiated CoverageBuy$23.00N/A
i
7/23/2018JMP SecuritiesInitiated CoverageOutperform$25.00N/A
i
7/23/2018JPMorgan Chase & Co.Initiated CoverageOutperform ➝ Overweight$21.00N/A
i
7/23/2018Raymond JamesInitiated CoverageMarket PerformN/A
i
8/9/2016Maxim GroupDowngradeBuy ➝ HoldN/A
i
7/27/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
i
7/27/2016Compass PointDowngradeBuy ➝ Neutral$19.50N/A
i
7/26/2016Sandler O'NeillDowngradeBuy ➝ HoldN/A
i
7/11/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
5/18/2016Sandler O'NeillUpgradeHold ➝ BuyN/A
i
5/13/2016Compass PointUpgradeNeutral ➝ Buy$16.50N/A
i
Rating by Jesus Bueno at Compass Point
4/28/2016Raymond JamesDowngradeStrong-Buy ➝ Outperform$17.00N/A
i
(Data available from 3/4/2016 forward)
EverQuote logo
EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. Its online marketplace offers consumers shopping for auto, home and renters, life, health, and commercial insurance. The company serves carriers, agents, and indirect distributors and aggregators. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $40.74
$40.52
$43.44

50 Day Range

MA: $45.83
$38.17
$51.82

52 Week Range

Now: $40.74
$21.00
$63.44

Volume

3,000 shs

Average Volume

328,590 shs

Market Capitalization

$1.13 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of EverQuote?

The following Wall Street sell-side analysts have issued research reports on EverQuote in the last year: Bank of America Co., Canaccord Genuity, JMP Securities, JPMorgan Chase & Co., Needham & Company LLC, Oppenheimer Holdings Inc., Raymond James, Stephens, and Zacks Investment Research.
View the latest analyst ratings for EVER.

What is the current price target for EverQuote?

7 Wall Street analysts have set twelve-month price targets for EverQuote in the last year. Their average twelve-month price target is $57.43, suggesting a possible upside of 30.3%. Oppenheimer Holdings Inc. has the highest price target set, predicting EVER will reach $70.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $48.00 for EverQuote in the next year.
View the latest price targets for EVER.

What is the current consensus analyst rating for EverQuote?

EverQuote currently has 1 sell rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EVER will outperform the market and that investors should add to their positions of EverQuote.
View the latest ratings for EVER.

What other companies compete with EverQuote?

Other companies that are similar to EverQuote include Sabre, 21Vianet Group, DouYu International, Rackspace Technology, Cardlytics, Switch, Yalla Group, Pluralsight, SVMK, Health Catalyst, Internet Initiative Japan, Eventbrite, Model N, Qutoutiao and GAN.

How do I contact EverQuote's investor relations team?

EverQuote's physical mailing address is 210 BROADWAY, CAMBRIDGE MA, 02139. The company's listed phone number is 855 522 3444 and its investor relations email address is [email protected] The official website for EverQuote is www.everquote.com.